ABVC BioPharma, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $4.7M | $12.1M | $2.7M |
| Jun 2022 | $4.6M | $13.8M | $2.9M |
| Sep 2022 | $4.8M | $10.5M | $1.3M |
| Dec 2022 | $6.3M | $9.6M | $85.3K |
| Mar 2023 | $9.0M | $10.7M | $1.1M |
| Jun 2023 | $9.7M | $9.3M | $99.3K |
| Sep 2023 | $7.5M | $16.6M | $500.1K |
| Dec 2023 | $6.5M | $7.8M | $60.2K |
| Mar 2024 | $6.5M | $8.0M | $30.5K |
| Jun 2024 | $6.5M | $8.0M | $124.3K |
| Sep 2024 | $6.4M | $7.8M | $137.3K |
| Dec 2024 | $6.8M | $7.5M | $248.4K |
| Mar 2025 | $6.9M | $14.9M | $152.2K |
| Jun 2025 | $6.8M | $16.2M | $388.3K |
| Sep 2025 | $6.7M | $21.2M | $192.1K |
| Dec 2025 | $7.8M | $21.1M | $681.5K |
| Mar 2026 | $6.9M | $19.7M | $140.3K |
| Jun 2026 | $7.1M | $19.4M | $31.9K |